Annual Drug Patent Expirations for MYFEMBREE
Myfembree is a drug marketed by Myovant Sciences and is included in one NDA. There are four patents protecting this drug.
This drug has seventy patent family members in twenty-nine countries.
The generic ingredient in MYFEMBREE is estradiol; norethindrone acetate; relugolix. Additional details are available on the estradiol; norethindrone acetate; relugolix profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
